A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
for Sickle Cell Disease
6 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 2 - 50
Code: NCT05736419·Phase 2·Recruiting